Animalcare Takes Over UK Distribution Of Danilon Gold
2 years ago 
492 views
Animalcare has taken over as the UK distributor of Danilon® Gold, the leading equine pain management NSAID.
With low ulcerogenic potential and excellent compliance, Danilon® Gold is trusted by many owners. It is used to relieve the pain caused by musculoskeletal conditions, such as osteoarthritis (OA), bursitis, laminitis, and soft tissue inflammation in their horses.
Some oral NSAIDs have been shown in increase the risk of gastric irritation¹ - a potential cause for concern for both veterinary surgeons and owners, particularly for the treatment of chronic conditions. However, in gastric studies², horses given Danilon® Gold showed a reduced number of ulcers and those that did appear were less severe. The area of gastric mucosa affected was also five times less.
Accurate administration is critical for clinical success. To support this, Danilon® Gold is presented in a coloured granule formulation and is now available in both 3g and 10g sachets. Acceptance by the horse is also key and Danilon® Gold’s palatability offers excellent proven voluntary intake.
Animalcare will officially re-launch Danilon® at this year’s BEVA Congress at the ACC in Liverpool in early September.
Commenting, Animalcare Brand Manager Kai Crawshaw said: “As the original marketing authorisation holder of Danilon® Gold, we are delighted that we are now distributing this incredible product in the UK.
“Danilon® joins our focused suite of products for veterinarians to help them ensure the optimum health and welfare of their equine patients. We can’t wait to celebrate the launch at BEVA Congress.”
¹ Banse H.E., et al. (2018) Prevalence of and risk factors for equine glandular and squamous gastric disease in polo horses. Can Vet J. 59(8):880-884
²Monreal L., et al. (2004) Lower gastric ulcerogenic effect of Suxibuzone compared to phenylbutazone when administered orally to horses. Res. Vet. Sci. 76, 145-149
About Animalcare
Animalcare is a sustainable and passionate organisation committed to leading in animal health through innovative and trusted products and services to support the veterinary profession. It has recently launched its first novel product - Daxocox®. It is the first weekly oral NSAID and achieves not only significant improvement in the clinical signs associated with the pain of osteoarthritis (OA) in dogs, but may also help to reduce the risk of OA breakthrough pain.
Visitwww.animalcare.co.uk
Follow Animalcare at:
https://www.facebook.com/animalcareUK
https://twitter.com/animalcareltd
https://www.linkedin.com/company/animalcare-uk/
30 August 2022
For further information:
Rebecca George, George PR
Email: [email protected]
Tel: 01449 737281/07974 161108
More from Animalcare
